Logo image of DRIO

DARIOHEALTH CORP (DRIO) Stock Fundamental Analysis

NASDAQ:DRIO - US23725P2092 - Common Stock

10.4 USD
+9.92 (+2066.67%)
Last: 8/28/2025, 2:59:01 PM
Fundamental Rating

3

Taking everything into account, DRIO scores 3 out of 10 in our fundamental rating. DRIO was compared to 35 industry peers in the Health Care Technology industry. DRIO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, DRIO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year DRIO has reported negative net income.
In the past year DRIO has reported a negative cash flow from operations.
In the past 5 years DRIO always reported negative net income.
In the past 5 years DRIO always reported negative operating cash flow.
DRIO Yearly Net Income VS EBIT VS OCF VS FCFDRIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

DRIO's Return On Assets of -39.18% is on the low side compared to the rest of the industry. DRIO is outperformed by 68.57% of its industry peers.
DRIO has a worse Return On Equity (-66.33%) than 65.71% of its industry peers.
Industry RankSector Rank
ROA -39.18%
ROE -66.33%
ROIC N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
DRIO Yearly ROA, ROE, ROICDRIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 -600 -800

1.3 Margins

Looking at the Gross Margin, with a value of 54.98%, DRIO is in line with its industry, outperforming 51.43% of the companies in the same industry.
In the last couple of years the Gross Margin of DRIO has grown nicely.
DRIO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
DRIO Yearly Profit, Operating, Gross MarginsDRIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

4

2. Health

2.1 Basic Checks

DRIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
DRIO has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DRIO has been increased compared to 5 years ago.
Compared to 1 year ago, DRIO has an improved debt to assets ratio.
DRIO Yearly Shares OutstandingDRIO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DRIO Yearly Total Debt VS Total AssetsDRIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

DRIO has an Altman-Z score of -5.96. This is a bad value and indicates that DRIO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.96, DRIO is doing worse than 80.00% of the companies in the same industry.
DRIO has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.48, DRIO is not doing good in the industry: 65.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Altman-Z -5.96
ROIC/WACCN/A
WACC12.99%
DRIO Yearly LT Debt VS Equity VS FCFDRIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

DRIO has a Current Ratio of 3.30. This indicates that DRIO is financially healthy and has no problem in meeting its short term obligations.
DRIO has a better Current ratio (3.30) than 74.29% of its industry peers.
A Quick Ratio of 2.83 indicates that DRIO has no problem at all paying its short term obligations.
The Quick ratio of DRIO (2.83) is better than 68.57% of its industry peers.
Industry RankSector Rank
Current Ratio 3.3
Quick Ratio 2.83
DRIO Yearly Current Assets VS Current LiabilitesDRIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 48.03% over the past year.
DRIO shows a strong growth in Revenue. In the last year, the Revenue has grown by 41.77%.
Measured over the past years, DRIO shows a very strong growth in Revenue. The Revenue has been growing by 29.03% on average per year.
EPS 1Y (TTM)48.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
Revenue 1Y (TTM)41.77%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%-14.16%

3.2 Future

DRIO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.52% yearly.
The Revenue is expected to grow by 18.06% on average over the next years. This is quite good.
EPS Next Y21.85%
EPS Next 2Y-17.91%
EPS Next 3Y-23.68%
EPS Next 5Y16.52%
Revenue Next Year-0.42%
Revenue Next 2Y9.13%
Revenue Next 3Y13.39%
Revenue Next 5Y18.06%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DRIO Yearly Revenue VS EstimatesDRIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
DRIO Yearly EPS VS EstimatesDRIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 -10 -20 -30 -40

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DRIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DRIO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DRIO Price Earnings VS Forward Price EarningsDRIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRIO Per share dataDRIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

A cheap valuation may be justified as DRIO's earnings are expected to decrease with -23.68% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.91%
EPS Next 3Y-23.68%

More info and screens

0

5. Dividend

5.1 Amount

DRIO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DARIOHEALTH CORP

NASDAQ:DRIO (8/28/2025, 2:59:01 PM)

10.4

+9.92 (+2066.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners16.6%
Inst Owner Change-4.49%
Ins Owners8.34%
Ins Owner Change6.28%
Market Cap473.20M
Analysts82
Price Target2.26 (-78.27%)
Short Float %8.28%
Short Ratio16.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.36%
Min EPS beat(2)-17.64%
Max EPS beat(2)24.37%
EPS beat(4)3
Avg EPS beat(4)22.65%
Min EPS beat(4)-17.64%
Max EPS beat(4)73.53%
EPS beat(8)6
Avg EPS beat(8)29.38%
EPS beat(12)9
Avg EPS beat(12)23.21%
EPS beat(16)10
Avg EPS beat(16)17.25%
Revenue beat(2)0
Avg Revenue beat(2)-17.61%
Min Revenue beat(2)-23.78%
Max Revenue beat(2)-11.45%
Revenue beat(4)1
Avg Revenue beat(4)-8.98%
Min Revenue beat(4)-23.78%
Max Revenue beat(4)0.92%
Revenue beat(8)1
Avg Revenue beat(8)-13.89%
Revenue beat(12)4
Avg Revenue beat(12)-8.68%
Revenue beat(16)5
Avg Revenue beat(16)-7.65%
PT rev (1m)-15.71%
PT rev (3m)-17.03%
EPS NQ rev (1m)36.21%
EPS NQ rev (3m)38.34%
EPS NY rev (1m)44.44%
EPS NY rev (3m)-33.18%
Revenue NQ rev (1m)-21.85%
Revenue NQ rev (3m)57.82%
Revenue NY rev (1m)-16.64%
Revenue NY rev (3m)-13.56%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 17.43
P/FCF N/A
P/OCF N/A
P/B 7.4
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)-0.86
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS0.6
BVpS1.41
TBVpS-0.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.18%
ROE -66.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.98%
FCFM N/A
ROA(3y)-51.31%
ROA(5y)-65.11%
ROE(3y)-81.98%
ROE(5y)-91.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y36.46%
GM growth 5Y7.37%
F-Score4
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.03%
Cap/Sales 0.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.3
Quick Ratio 2.83
Altman-Z -5.96
F-Score4
WACC12.99%
ROIC/WACCN/A
Cap/Depr(3y)8.55%
Cap/Depr(5y)19.33%
Cap/Sales(3y)1.81%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)48.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
EPS Next Y21.85%
EPS Next 2Y-17.91%
EPS Next 3Y-23.68%
EPS Next 5Y16.52%
Revenue 1Y (TTM)41.77%
Revenue growth 3Y9.65%
Revenue growth 5Y29.03%
Sales Q2Q%-14.16%
Revenue Next Year-0.42%
Revenue Next 2Y9.13%
Revenue Next 3Y13.39%
Revenue Next 5Y18.06%
EBIT growth 1Y32.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year71.48%
EBIT Next 3Y25.71%
EBIT Next 5Y16.13%
FCF growth 1Y19.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.88%
OCF growth 3YN/A
OCF growth 5YN/A